SP110 Could be Used as a Potential Predictive and Therapeutic Biomarker for Oral Cancer
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01212-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Guoqiang Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Human Disease Animal Model, Shanxi Medical University, Road Xinjia…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanxi Scholarship Council of China, the special found for Science and Technology Innovation Teams of Shanxi Province.
Abstract (Originalsprache)
The morbidity of oral squamous cell carcinoma (OSCC) has been rising year after year, making it a major global health issue. But the molecular pathogenesis of OSCC is currently unclear. To study the potential pathogenesis of OSCC, the differentially expressed genes (DEGs) were screened, and multiple databases were used to perform the tumor stage, expression, prognosis, protein-protein interaction (PPI) networks, modules, and the functional enrichment analysis. Moreover, we have identified SP110 as the key candidate gene and conducted various analyses on it using multiple databases. The research indicated that there were 211 common DEGs, and they were enriched in various GO terms and pathways. Meanwhile, one DEG is significantly related to short disease-free survival, four are associated with overall survival, and 12 DEGs have close ties with tumor staging. Additionally, the SP110 is significantly associated with methylation level, HPV status, tumor staging, gender, race, tumor grade, age, and overall/disease-free survival of oral cancer patients, as well as the immune process. The copy number variation of SP110 significantly affected the abundance of immune infiltration. Therefore, we speculate that SP110 could be used as the diagnostic and therapeutic biomarker for OSCC, and can help to further understand oral carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Human Disease Animal Model, Shanxi Medical University, Road Xinjian 56, Taiyuan, 030001, China.
- Shanxi Medical University School of Basic Medical Science, Taiyuan, 030001, China.
- Laboratory Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Human Disease Animal Model, Shanxi Medical University, Road Xinjian 56, Taiyuan, 030001, China. ykdsgh@sxmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shanxi Scholarship Council of China
- the special found for Science and Technology Innovation Teams of Shanxi Province
- the Central Government's Guide to Local Science and Technology Development Fund
- Natural Science Foundation of Shanxi Province
Zitieren
APA
Xu, G., Wang, X., Qin, L., Gao, J., & Song, G. (2025). SP110 Could be Used as a Potential Predictive and Therapeutic Biomarker for Oral Cancer. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01212-8
Vancouver
Xu G, Wang X, Qin L, Gao J, Song G. SP110 Could be Used as a Potential Predictive and Therapeutic Biomarker for Oral Cancer. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01212-8
BibTeX
@article{Xu2025,
author = {Xu, Guoqiang and Wang, Xiaotang and Qin, Litao and Gao, Jiping and Song, Guohua},
title = {SP110 Could be Used as a Potential Predictive and Therapeutic Biomarker for Oral Cancer},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01212-8}
}
EUVIMED